Kardigan, Inc. (KARD)
NASDAQ: KARD · Real-Time Price · USD
22.24
-0.53 (-2.33%)
At close: Jun 23, 2026, 4:00 PM EDT
21.40
-0.84 (-3.78%)
After-hours: Jun 23, 2026, 5:09 PM EDT
Kardigan Employees
Kardigan had 241 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
241
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$954,328
Market Cap
1.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 241 | 0 | - |
| Dec 31, 2025 | 241 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| ADMA Biologics | 647 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Nuvation Bio | 307 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Mesoblast | 81 |
KARD News
- 1 day ago - Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire
- 1 day ago - Opening Day: Kardigan races higher after debut on Nasdaq - TheFly
- 5 days ago - Kardigan rises in Nasdaq debut after upsized $400 million IPO - Reuters
- 5 days ago - Kardigan opens at $16.25, IPO priced at $16.00 - TheFly
- 5 days ago - Kardigan 25M share IPO priced at $16.00 - TheFly
- 5 days ago - Kardigan Announces Pricing of Upsized Initial Public Offering - Business Wire
- 12 days ago - Heart drug developer Kardigan targets $1.4 billion valuation in US IPO - Reuters
- 4 weeks ago - Cardiovascular drug developer Kardigan files for US IPO - Reuters